Skip to main content
Article
Systemic irinotecan and regional floxuridine after hepatic cytoreduction in 185 patients with unresectable colorectal cancer metastases
Annals of Surgical Oncology (2002)
  • David A. Litvak, Division of Surgical Oncology, John Wayne Cancer Institute, Saint John’s Health Center, Santa Monica,
  • Thomas F. Wood, Division of Surgical Oncology, John Wayne Cancer Institute, Saint John’s Health Center, Santa Monica,
  • George J. Tsioulias, Division of Surgical Oncology, John Wayne Cancer Institute, Saint John’s Health Center, Santa Monica,
  • Mathew Chung, Division of Surgical Oncology, John Wayne Cancer Institute, Saint John’s Health Center, Santa Monica,
  • Sant P. Chawla, Century City Hospital, Los Angeles,
  • Leland J. Foshag, Century City Hospital, Los Angeles,
  • Donald L. Morton, Division of Surgical Oncology, John Wayne Cancer Institute, Saint John’s Health Center, Santa Monica,
  • Kenneth P. Ramming, Division of Surgical Oncology, John Wayne Cancer Institute, Saint John’s Health Center, Santa Monica,
  • Anton J. Bilchik, Division of Surgical Oncology, John Wayne Cancer Institute, Saint John’s Health Center, Santa Monica,
Publication Date
March 1, 2002
DOI
10.1007/BF02557366
Citation Information
David A. Litvak, Thomas F. Wood, George J. Tsioulias, Mathew Chung, et al.. "Systemic irinotecan and regional floxuridine after hepatic cytoreduction in 185 patients with unresectable colorectal cancer metastases" Annals of Surgical Oncology Vol. 9 Iss. 2 (2002) p. 148 - 155
Available at: http://works.bepress.com/antonj-bilchik/185/